Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding

Saskia E. M Schols; Paola E. J. van der Meijden; René van Oerle; Joyce Curvers; Johan W. M Heemskerk; Elisabeth C. M. van Pampus

doi:10.1160/TH07-07-0438

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 99(01): 64-70
DOI: 10.1160/TH07-07-0438

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: Relation to bleeding

Saskia E. M Schols

¹Department of Biochemistry (CARIM), Maastricht University

²Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands

,

Paola E. J. van der Meijden

¹Department of Biochemistry (CARIM), Maastricht University

,

René van Oerle

¹Department of Biochemistry (CARIM), Maastricht University

²Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands

,

Joyce Curvers

³Catharina Hospital, Eindhoven, The Netherlands

,

Johan W. M Heemskerk

¹Department of Biochemistry (CARIM), Maastricht University

,

Elisabeth C. M. van Pampus

²Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands

› Author Affiliations

Abstract

Full Text

PDF Download

Keywords

Bleeding - dilutional coagulopathy - fibrinogen - platelets - thrombin generation

References

References
1 Johansson PI, Hansen MB, Sorensen H. Transfusion practice in massively bleeding patients: time for a change?. Vox Sang 2005; 89: 92-96.
2 Stanworth SJ, Brunskill SJ, Hyde CJ. et al. Is fresh frozen plasma clinically effective?. Br J Haematol 2004; 126: 139-152.
3 Hardy JF, de Moerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005; 89: 123-127.
4 Bux J. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion. Vox Sang 2005; 89: 1-10.
5 Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion. The effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-139.
6 Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth 2005; 95: 130-139.
7 Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 81-90.
8 Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements. An update on monitoring haemostatic response using thromboelastography. Haemophilia 2005; 11: 1-6.
9 Barrowcliffe TW. Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A. Haemophilia 2006; 12 S4: 23-29.
10 Nieuwenhuys CMA, Feijge MAH, Béguin S. et al. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma. Thromb Haemost 2000; 84: 1045-1051.
11 Vanschoonbeek K, Feijge MAH, Paquay M, Rosing J, Saris W, Kluft C. et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 2004; 24: 1734-1740.
12 Matthes GA. Options and cost effectiveness of multicomponent blood collection. Transfus Apher Sci 2002; 27: 115-121.
13 O’Shaughnessy DF, Atterbury C, Bolton Maggs P. et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
14 Chowdhury P, Saayman AG, Paulus U. et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
15 Hemker HC, Giesen P, Al Dieri R. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
16 Rosing J, Tans G, Govers-Riemslag JW. et al. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-283.
17 Vanschoonbeek K, Feijge MAH, van Kampen RJ, Kenis H, Hemker HC, Giesen PLA. et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma. J Thromb Haemost 2004; 2: 476-484.
18 Van der Meijden PEJ, Feijge MAH, Giesen PLA. et al. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost 2005; 93: 1128-1136.
19 Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-1285.
20 Al Dieri R, Alban S, Béguin S. et al. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J Thromb Haemost 2004; 2: 1395-1401.
21 Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 2006; 53: S40-S58.
22 Hemker HC, Al Dieri R, de Smedt E. et al. Thrombin generation, a function test of the haemostaticthrombotic system. Thromb Haemost 2006; 96: 553-561.
23 Heemskerk JWM, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88: 186-193.
24 Fries D, Haas T, Klingler A. et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy, a porcine model. Br J Anaesth 2006; 97: 460-467.
25 Kheirabadi BS, Crissey JM, Deguzman R. et al. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007; 62: 1352-1359.